KRONOX vs NEOGEN: Stock Comparison

Kronox Lab Sciences Limited vs Neogen Chemicals Limited

Live data: 31 July 2026, 4:08 PM IST • Source: NSE and company filings

Neogen Chemicals Limited is the larger company by market capitalisation. Kronox Lab Sciences Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Neogen Chemicals Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Kronox Lab Sciences Limited and Neogen Chemicals Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KRONOX is more favourable on 9 of 13 scored metrics and NEOGEN on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
NEOGEN is the larger company
₹5,540 Cr vs ₹563 Cr
P/E Ratio
KRONOX has a lower P/E
20.32x vs 150.45x
P/B Ratio
KRONOX has a lower P/B
4.84x vs 6.44x
EPS
NEOGEN has higher earnings per share
₹10.93 vs ₹7.45
Dividend Yield
KRONOX has a higher dividend yield
0.33% vs 0.05%
Revenue Growth (TTM YoY)
NEOGEN has faster revenue growth
21.6% vs 0%
EPS Growth (TTM YoY)
NEOGEN has faster EPS growth
375.9% vs 26.7%
Qtr Sales Growth
NEOGEN has stronger quarterly sales growth
21.6% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKRONOXNEOGEN
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricKRONOXNEOGEN
Live Price₹151.3₹2,023.1
Day Change-0.52%1.76%
Volume36,7121.75 L
52-Week High₹184.31₹2,374
52-Week Low₹96₹966.7
Distance from 52W High-17.91%-14.78%

Valuation

MetricKRONOXNEOGEN
Market Cap₹563 Cr₹5,540 Cr
P/E Ratio20.32x150.45x
P/B Ratio4.84x6.44x
EPS₹7.45₹10.93
Book Value₹31.64₹309.59
Dividend Yield0.33%0.05%

Growth

MetricKRONOXNEOGEN
Revenue Growth (TTM YoY)0%21.6%
EPS Growth (TTM YoY)26.7%375.9%
Qtr Sales Growth0%21.6%
Qtr Profit Growth26.6%23.7%

Profitability & Leverage

MetricKRONOXNEOGEN
ROE26.8%3.58%
ROCE36%6.46%
Net Margin27.21%3.33%
Operating Margin33.9%15.9%
Debt to Equity0.01x1.71x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKRONOXNEOGEN
Promoter Holding74.21%49.36% 1.92 pp
FII Holding0.04% 0.04 pp4.11% 0.34 pp
DII Holding2.07% 0.02 pp19.6% 2.88 pp
Public Holding23.67% 0.01 pp23.28% 1.44 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Kronox Lab Sciences Limited and Neogen Chemicals Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.